Trial · NCT07888556
Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study
NCT07888556, Not yet recruiting, Henan Cancer Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study. Trials, record NCT07888556. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888556
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study
- NCT number
- NCT07888556
- Status
- Not yet recruiting
- Enrollment
- 147 participants, estimated
- Lead sponsor
- Henan Cancer Hospital
- Conditions
- Advanced Breast Cancer
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 3-year PFS rate after treatment discontinuation | 3 years after treatment discontinuation | 3-year progression-free survival (PFS) rate after treatment discontinuation. PFS was defined as the time from treatment discontinuation to first documented disease progression (PD) or death from any cause, whichever occurred first. |
| Secondary | 1-year PFS rate after treatment discontinuation | 1 year after treatment discontinuation | 1-year progression-free survival (PFS) rate after treatment discontinuation. PFS was defined as the time from treatment discontinuation to first documented disease progression (PD) or death from any cause, whichever occurred first. |
| Secondary | 5-year PFS rate after treatment discontinuation | 5 years after treatment discontinuation | 5-year progression-free survival (PFS) rate after treatment discontinuation. PFS was defined as the time from treatment discontinuation to first documented disease progression (PD) or death from any cause, whichever occurred first. |
| Secondary | OS | up to 5 years | OS was defined as the time from initiation of best treatment to death for any cause; participants without death will be censored at the date of last follow-up. |
| Secondary | QOL | up to 5 years | Quality of Life (QOL) was defined as a comprehensive multi-dimensional index reflecting physical, psychological, social and environmental status. The FACT-B and GAD-7 scales will be used to assess patients' quality of life and influencing factors. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888556
GET https://conductscience.org/api/trials/v1/NCT07888556/registered